Baseline MRI predicts future attacks and disability in clinically isolated syndromes
Mar Tintoré(Vall d'Hebron Hospital Universitari), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Àlex Rovira(Centre National de la Recherche Scientifique), N. Téllez(Universitat Autònoma de Barcelona), Jordi Río(Universitat Autònoma de Barcelona), Manuel Comabella(Universitat Autònoma de Barcelona), Elisenda Grivé(Hebron University), Carlos Nos(Universitat Autònoma de Barcelona), R. Pelayo(Universitat Autònoma de Barcelona), Jaume Sastre‐Garriga(Universitat Autònoma de Barcelona)
Cited by 286
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k